Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 1
2005 4
2006 8
2007 4
2008 3
2009 1
2010 4
2011 1
2012 1
2013 2
2014 2
2015 4
2016 6
2017 2
2018 4
2019 5
2020 6
2021 3
2022 5
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.
Veyradier A, Boisseau P, Fressinaud E, Caron C, Ternisien C, Giraud M, Zawadzki C, Trossaert M, Itzhar-Baïkian N, Dreyfus M, d'Oiron R, Borel-Derlon A, Susen S, Bezieau S, Denis CV, Goudemand J; French Reference Center for von Willebrand disease. Veyradier A, et al. Among authors: goudemand j. Medicine (Baltimore). 2016 Mar;95(11):e3038. doi: 10.1097/MD.0000000000003038. Medicine (Baltimore). 2016. PMID: 26986123 Free PMC article.
von Willebrand factor: aging is better?
Goudemand J, Susen S. Goudemand J, et al. J Thromb Haemost. 2023 Dec;21(12):3357-3359. doi: 10.1016/j.jtha.2023.09.001. J Thromb Haemost. 2023. PMID: 38000853 No abstract available.
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
Pagliari MT, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour MR, Benítez Hidalgo O, Biguzzi E, Bodó I, Castaman G, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Mannucci PM, Federici AB, Eikenboom J, Peyvandi F. Pagliari MT, et al. Among authors: goudemand j. J Thromb Haemost. 2023 Apr;21(4):787-799. doi: 10.1016/j.jtha.2023.01.001. Epub 2023 Jan 11. J Thromb Haemost. 2023. PMID: 36792472 Free article.
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).
Susen S, Gruel Y, Godier A, Harroche A, Chambost H, Lasne D, Rauch A, Roullet S, Fontana P, Goudemand J, de Maistre E, Chamouard V, Wibaut B, Albaladejo P, Négrier C. Susen S, et al. Among authors: goudemand j. Haemophilia. 2019 Sep;25(5):731-737. doi: 10.1111/hae.13817. Epub 2019 Jul 11. Haemophilia. 2019. PMID: 31294904 Review.
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Volkers P, Hanschmann KM, Calvez T, Chambost H, Collins PW, Demiguel V, Hart DP, Hay CRM, Goudemand J, Ljung R, Palmer BP, Santagostino E, van Hardeveld EM, van den Berg M, Keller-Stanislawski B. Volkers P, et al. Among authors: goudemand j. Haemophilia. 2019 May;25(3):398-407. doi: 10.1111/hae.13747. Epub 2019 May 7. Haemophilia. 2019. PMID: 31066174 Review.
The Cost of Von Willebrand Disease in Europe: The CVESS Study.
Morgan G, Brighton S, Laffan M, Goudemand J, Franks B, Finnegan A. Morgan G, et al. Among authors: goudemand j. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221120583. doi: 10.1177/10760296221120583. Clin Appl Thromb Hemost. 2022. PMID: 35979588 Free PMC article.
Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
Van Belle E, Rauch A, Vincent F, Robin E, Kibler M, Labreuche J, Jeanpierre E, Levade M, Hurt C, Rousse N, Dally JB, Debry N, Dallongeville J, Vincentelli A, Delhaye C, Auffray JL, Juthier F, Schurtz G, Lemesle G, Caspar T, Morel O, Dumonteil N, Duhamel A, Paris C, Dupont-Prado A, Legendre P, Mouquet F, Marchant B, Hermoire S, Corseaux D, Moussa K, Manchuelle A, Bauchart JJ, Loobuyck V, Caron C, Zawadzki C, Leroy F, Bodart JC, Staels B, Goudemand J, Lenting PJ, Susen S. Van Belle E, et al. Among authors: goudemand j. N Engl J Med. 2016 Jul 28;375(4):335-44. doi: 10.1056/NEJMoa1505643. N Engl J Med. 2016. PMID: 27464202 Free article.
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.
Dubois MD, Peyron I, Pierre-Louis ON, Pierre-Louis S, Rabout J, Boisseau P, de Jong A, Susen S, Goudemand J, Neviere R, Fuseau P, Christophe OD, Lenting PJ, Denis CV, Casari C. Dubois MD, et al. Among authors: goudemand j. Res Pract Thromb Haemost. 2022 Jun 15;6(4):e12737. doi: 10.1002/rth2.12737. eCollection 2022 May. Res Pract Thromb Haemost. 2022. PMID: 35734101 Free PMC article.
68 results